Commentary on Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer: Millikan RE, Wen S, Pagliaro LC, Brown MA, Moomey B, Do KA, Logothetis CJ, Department of Genitourinary Medical Oncology, University of Texas, M.D. Anderson Cancer Center, Houston, TX